No association of CpG island methylator phenotype and colorectal cancer survival: population-based study

被引：0
|
作者：
Min Jia
Lina Jansen
Viola Walter
Katrin Tagscherer
Wilfried Roth
Esther Herpel
Matthias Kloor
Hendrik Bläker
Jenny Chang-Claude
Hermann Brenner
Michael Hoffmeister
机构：
[1] German Cancer Research Center (DKFZ),Division of Clinical Epidemiology and Aging Research
[2] Institute of Pathology,Department of Applied Tumor Biology
[3] Heidelberg University Hospital,Division of Cancer Epidemiology
[4] Institute of Pathology,Division of Preventive Oncology
[5] University Medical Center Mainz,undefined
[6] NCT Tissue Bank,undefined
[7] National Center for Tumor Diseases (NCT),undefined
[8] Institute of Pathology,undefined
[9] Heidelberg University Hospital,undefined
[10] Institute of Pathology,undefined
[11] Charité University Medicine,undefined
[12] German Cancer Research Center (DKFZ),undefined
[13] German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT),undefined
[14] German Cancer Consortium (DKTK),undefined
[15] German Cancer Research Center (DKFZ),undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
molecular pathological epidemiology; DNA methylation; malignant; subtype; prognosis; colorectal cancer; CRC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1359 / 1366
页数：7
相关论文
共 50 条
  • [41] The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer
    Zlobec, Inti
    Bihl, Michel P.
    Foerster, Anja
    Rufle, Alex
    Lugli, Alessandro
    HISTOPATHOLOGY, 2012, 61 (05) : 777 - 787
  • [42] A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps
    Hokazono, Koji
    Ueki, Takashi
    Nagayoshi, Kinuko
    Nishioka, Yasunobu
    Hatae, Tatsunobu
    Koga, Yutaka
    Hirahashi, Minako
    Oda, Yoshinao
    Tanaka, Masao
    ONCOLOGY LETTERS, 2014, 8 (05) : 1937 - 1944
  • [43] Impact of CpG island methylator phenotype and microsatellite instability on tumor budding in colorectal cancer
    Zlobec, I.
    Bihl, M.
    Koelzer, V.
    Foerster, A.
    Rufle, A.
    Lugli, A.
    VIRCHOWS ARCHIV, 2011, 459 : S19 - S20
  • [44] Identification of altered molecular pathways in colorectal cancer with CpG island methylator phenotype (CIMP)
    Fedorova, M.
    Krasnov, G.
    Snezhkina, A.
    Guvatova, Z.
    Kharitonov, S.
    Pudova, E.
    Slavnova, E.
    Chernichenko, M.
    Sidorov, D.
    Kiseleva, M.
    Kaprin, A.
    Kudryavtseva, A.
    VIRCHOWS ARCHIV, 2018, 473 : S136 - S136
  • [45] Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review
    Jia, Min
    Gao, Xu
    Zhang, Yan
    Hoffmeister, Michael
    Brenner, Hermann
    CLINICAL EPIGENETICS, 2016, 8 : 1 - 14
  • [46] CpG island methylator phenotype (CIMP) in Puerto Rican Hispanic colorectal cancer patients
    Bernabe-Dones, Raul D.
    Cruz-Correa, Marcia R.
    Castro, Cristina I.
    Lacourt, Mercedes Y.
    Rodriguez, Heriberto
    Castillo, Xiomara M.
    Marcano, Isabel C.
    Nunez, Cristina
    Baez, Noelia
    Lozada, Maria E.
    Maldonado, Meredid S.
    Oliveras, Luis F.
    Cardona, Alberto
    CANCER RESEARCH, 2011, 71
  • [47] Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin
    Cohen, Stacey A.
    Wu, Chen
    Yu, Ming
    Gourgioti, Georgia
    Wirtz, Ralph
    Raptou, Georgia
    Gkakou, Chryssa
    Kotoula, Vassiliki
    Pentheroudakis, George
    Papaxoinis, George
    Karavasilis, Vasilios
    Pectasides, Dimitrios
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    CLINICAL COLORECTAL CANCER, 2016, 15 (02) : 164 - 169
  • [48] CPG ISLAND METHYLATOR PHENOTYPE IS ASSOCIATED WITH THE EFFICACY OF CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Shimodaira, H.
    Zhang, X.
    Komine, K.
    Takahashi, M.
    Takahashi, S.
    Ishioka, C.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History
    Weisenberger, Daniel J.
    Levine, A. Joan
    Long, Tiffany I.
    Buchanan, Daniel D.
    Walters, Rhiannon
    Clendenning, Mark
    Rosty, Christophe
    Joshi, Amit D.
    Stern, Mariana C.
    Le Marchand, Loic
    Lindor, Noralane M.
    Daftary, Darshana
    Gallinger, Steven
    Selander, Teresa
    Bapat, Bharati
    Newcomb, Polly A.
    Campbell, Peter T.
    Casey, Graham
    Ahnen, Dennis J.
    Baron, John A.
    Haile, Robert W.
    Hopper, John L.
    Young, Joanne P.
    Laird, Peter W.
    Siegmund, Kimberly D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 512 - 519
  • [50] CpG island methylator phenotype and patients with multiple colorectal cancers.
    Grady, WM
    Markowitz, S
    Willis, J
    GASTROENTEROLOGY, 2000, 118 (04) : A46 - A46
12345